LHYFE SAS (LHYFE.PA) Stock Fundamental Analysis
Europe - EPA:LHYFE - FR0014009YQ1 - Common Stock
3.015 EUR
+0.02 (+0.84%)
We assign a fundamental rating of 2 out of 10 to LHYFE. LHYFE was compared to 63 industry peers in the Oil, Gas & Consumable Fuels industry. LHYFE has a bad profitability rating. Also its financial health evaluation is rather negative. LHYFE is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
LHYFE had negative earnings in the past year.
In the past year LHYFE has reported a negative cash flow from operations.
LHYFE had negative earnings in each of the past 5 years.
In the past 5 years LHYFE always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -15.49%, LHYFE is not doing good in the industry: 90.48% of the companies in the same industry are doing better.
With a Return On Equity value of -72.30%, LHYFE is not doing good in the industry: 90.48% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.49% | ||
| ROE | -72.3% | ||
| ROIC | N/A |
ROA(3y)-14.91%
ROA(5y)-15.02%
ROE(3y)-30.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LHYFE has a Gross Margin of 80.73%. This is amongst the best in the industry. LHYFE outperforms 85.71% of its industry peers.
LHYFE's Gross Margin has improved in the last couple of years.
LHYFE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 80.73% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.82%
GM growth 5YN/A
2. Health
2.1 Basic Checks
LHYFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LHYFE has about the same amount of shares outstanding.
Compared to 5 years ago, LHYFE has more shares outstanding
The debt/assets ratio for LHYFE is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -0.47, we must say that LHYFE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.47, LHYFE is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
LHYFE has a Debt/Equity ratio of 1.55. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.55, LHYFE is doing worse than 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.47 |
ROIC/WACCN/A
WACC7.53%
2.3 Liquidity
A Current Ratio of 1.69 indicates that LHYFE should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.69, LHYFE is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.68 indicates that LHYFE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.68, LHYFE is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
The earnings per share for LHYFE have decreased strongly by -16.57% in the last year.
Looking at the last year, LHYFE shows a very strong growth in Revenue. The Revenue has grown by 209.99%.
Measured over the past years, LHYFE shows a very strong growth in Revenue. The Revenue has been growing by 195.81% on average per year.
EPS 1Y (TTM)-16.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.16%
Revenue 1Y (TTM)209.99%
Revenue growth 3Y195.81%
Revenue growth 5YN/A
Sales Q2Q%177.45%
3.2 Future
The Earnings Per Share is expected to grow by 14.11% on average over the next years. This is quite good.
The Revenue is expected to grow by 129.95% on average over the next years. This is a very strong growth
EPS Next Y-5.47%
EPS Next 2Y14.17%
EPS Next 3Y14.11%
EPS Next 5YN/A
Revenue Next Year111.33%
Revenue Next 2Y290.88%
Revenue Next 3Y183.6%
Revenue Next 5Y129.95%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
LHYFE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LHYFE. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as LHYFE's earnings are expected to grow with 14.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.17%
EPS Next 3Y14.11%
5. Dividend
5.1 Amount
LHYFE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:LHYFE (11/20/2025, 7:00:00 PM)
3.015
+0.02 (+0.84%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners8.93%
Inst Owner ChangeN/A
Ins Owners21.32%
Ins Owner ChangeN/A
Market Cap144.96M
Revenue(TTM)8.07M
Net Income(TTM)-36.79M
Analysts84
Price Target4.35 (44.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.22%
PT rev (3m)-16.34%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-17.96%
EPS NY rev (3m)-6.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)6.5%
Revenue NY rev (3m)-52.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 17.97 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.85 | ||
| P/tB | 4.79 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0.17
BVpS1.06
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.49% | ||
| ROE | -72.3% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 80.73% | ||
| FCFM | N/A |
ROA(3y)-14.91%
ROA(5y)-15.02%
ROE(3y)-30.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.82%
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.55 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 483.84% | ||
| Cap/Sales | 391.28% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | -0.47 |
F-Score4
WACC7.53%
ROIC/WACCN/A
Cap/Depr(3y)957.78%
Cap/Depr(5y)2682.27%
Cap/Sales(3y)1925.18%
Cap/Sales(5y)13341.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.16%
EPS Next Y-5.47%
EPS Next 2Y14.17%
EPS Next 3Y14.11%
EPS Next 5YN/A
Revenue 1Y (TTM)209.99%
Revenue growth 3Y195.81%
Revenue growth 5YN/A
Sales Q2Q%177.45%
Revenue Next Year111.33%
Revenue Next 2Y290.88%
Revenue Next 3Y183.6%
Revenue Next 5Y129.95%
EBIT growth 1Y-10.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.47%
EBIT Next 3Y36.05%
EBIT Next 5Y27.12%
FCF growth 1Y-63.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.98%
OCF growth 3YN/A
OCF growth 5YN/A
LHYFE SAS / LHYFE.PA FAQ
Can you provide the ChartMill fundamental rating for LHYFE SAS?
ChartMill assigns a fundamental rating of 2 / 10 to LHYFE.PA.
Can you provide the valuation status for LHYFE SAS?
ChartMill assigns a valuation rating of 0 / 10 to LHYFE SAS (LHYFE.PA). This can be considered as Overvalued.
What is the profitability of LHYFE stock?
LHYFE SAS (LHYFE.PA) has a profitability rating of 1 / 10.
What is the financial health of LHYFE SAS (LHYFE.PA) stock?
The financial health rating of LHYFE SAS (LHYFE.PA) is 2 / 10.